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Monsanto Company, Saint Louis, MO, USA
Bacillus thuringiensis (Bt) microbial pesticides have a 50-year history of safety in
agriculture. Cry proteins are among the active insecticidal ingredients in these pesticides,
and genes coding for Cry proteins have been introduced into agricultural crops using
modern biotechnology. The Cry gene sequences are often modified to enable effective
expression in planta and several Cry proteins have been modified to increase biological
activity against the target pest(s). Additionally, the domains of different but structurally
conserved Cry proteins can be combined to produce chimeric proteins with enhanced
insecticidal properties. Environmental studies are performed and include invertebrates,
mammals, and avian species. Mammalian studies used to support the food and
feed safety assessment are also used to support the wild mammal assessment. In
addition to the NTO assessment, the environmental assessment includes a comparative
assessment between the Bt crop and the appropriate conventional control that is
genetically similar but lacks the introduced trait to address unintended effects. Specific
phenotypic, agronomic, and ecological characteristics are measured in the Bt crop and
the conventional control to evaluate whether the introduction of the insect resistance
has resulted in any changes that might cause ecological harm in terms of altered weed
characteristics, susceptibility to pests, or adverse environmental impact. Additionally,
environmental interaction data are collected in field experiments for Bt crop to evaluate
potential adverse effects. Further to the agronomic and phenotypic evaluation, potential
movement of transgenes from a genetically modified crop plants into wild relatives is
assessed for a new pest resistance gene in a new crop. This review summarizes the
evidence for safety of crops containing Cry proteins for humans, livestock, and other
non-target organisms.
Keywords: Bacillus thuringiensis, Cry proteins, genetically modified crops, safety assessment, food and feed
safety
Introduction
The insecticidal activity of Bacillus thuringiensis (Bt) was discovered in 1901 in Japan, where the
bacterium was isolated from infected silkworms, and was later (1911) rediscovered in Germany
in infected ﬂour moth chrysalids (reviewed in Sanchis, 2011). For over 50 years, Bt strains
and their insecticidal proteins have been used as commercial biological pesticides (Betz et al.,
2000; Sanchis, 2011). The ﬁrst U.S. registration of a Bt microbial product was in 1961; by 1998,
there were approximately 180 products registered in the U.S. Environmental Protection Agency
(EPA, 1998a,b). There are reported to be over 120 microbial products in the European Union
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(Hammond and Koch, 2012) and approximately 276 Btmicrobial
formulations registered in China (Huang et al., 2007). In China,
10s of 1000s of tons of Bt microbial formulations are applied to
food crops, forests, and potable water, the latter as a means of
controlling mosquitoes and other insect vectors of human dis-
ease (WHO/IPCS, 1999; Ziwen, 2010). The extensive use of Bt
microbial pesticides worldwide is likely due to their speciﬁcity
against a limited number of target insect species that greatly limits
the potential for impacts to beneﬁcial and non-target organisms
(NTOs; Receptor-Mediated Selectivity of Bt Cry Proteins) and
lack of environmental persistence of Cry proteins (WHO/IPCS,
1999; Betz et al., 2000; OECD, 2007; Federici and Siegel, 2008).
Because of the eﬃcacy, safety to humans and NTOs, and
favorable environmental persistence proﬁle of Bt microbial for-
mulations, the active proteins in these formulations have been
isolated and optimized for expression in plants to make genet-
ically modiﬁed (GM) crops that are resistant to target insects.
The adoption by farmers of these Bt protein–containing crops
has been dramatic, with 75.9 million hectares of Bt crops planted
in 2013 representing over 40% of all GM crops planted that
year (James, 2013). The large-scale adoption of the Bt crops can
be attributed to increased crop productivity and reduced need
for chemical pesticides which result in a reduced environmental
footprint for agriculture.
This review summarizes primarily what is known about food
safety, however, as part of this review the mechanism of action,
taxonomic speciﬁcity, and environmental safety of Bt proteins
particularly Cry proteins has been included. The large amount of
safety information that has been generated on both Bt microbial
insecticides andGMcrops that produce speciﬁc Bt proteins is dis-
cussed, and technical assessments of the small number of studies
that have raised concerns about the safety of Bt Cry proteins are
provided. The many beneﬁts of Bt crops beyond insect control
per se are also highlighted.
Mechanism of Action of Bt Cry Protein
Insecticidal Activity
Bt is a Gram-positive, aerobic bacterium found in a variety of out-
door environments (Federici and Siegel, 2008). When nutrients
or oxygen are insuﬃcient for vegetative growth, the bacterium
sporulates, producing a spore, and a parasporal body contain-
ing one or more insecticidal crystal proteins (Federici and Siegel,
2008). Three main types of insecticidal proteins are known to
be produced by Bt microbes: Cry (for crystal) proteins, Cyt (for
cytolytic) proteins, and toxins that are produced and secreted
during vegetative growth. The diversity within and among these
protein classes provides activity against a range of larval insects
(van Frankenhuyzen and Nystrom, 2002; Crickmore et al., 2014).
Cry proteins are active against lepidopteran insects and some
variants are also active against dipteran insects, coleopteran
insects, or nematodes. Cyt proteins are toxic to mosquito and
black ﬂy larvae and a few beetle species (Soberón et al., 2013). VIP
proteins, which are produced and secreted during the vegetative
growth stage, have activity against coleopteran and lepidopteran
insect species. Although each of these components contributes to
the overall insecticidal activity of microbial Bt products, the Cry
proteins are considered the most important component of com-
mercial Bt formulations. It is for this reason that the majority of
commercially available GM crops with insecticidal activity have
been developed to express one or more Bt Cry proteins, which
are the focus of this review.
The mode of action of Cry proteins has been extensively stud-
ied and reviewed (WHO/IPCS, 1999; Betz et al., 2000; Siegel,
2001; Bravo et al., 2007; OECD, 2007; Federici and Siegel, 2008;
Soberón et al., 2010). Unlike most chemical pesticides, which are
contact insecticides, Cry proteins are eﬀective only when ingested
by the insect. The Cry proteins are approximately 70–140 kDa
(Höfte andWhiteley, 1989). Within the alkaline conditions in the
Lepidopteran insect gastrointestinal (GI) tract, proteases cleave
the protoxin (inactive) form into an active toxic/toxin form.
The activated Cry molecules typically bind to speciﬁc recep-
tors on mid-GI-tract epithelial cells of target larval insects and
then oligomerize, forming pores consisting of four to six Cry
molecules each in cellular membranes. These pores enable excess
cations to enter the cell, causing osmotic imbalance. The aﬀected
midgut cells take in water, swell, and lyse, eventually resulting
in death of the insect (Federici and Siegel, 2008; Soberón et al.,
2010). Receptors to which Cry proteins bind in insects include
cadherin-like glycoproteins, which appear to be a primary recep-
tor for some Cry proteins, and glycosylphosphatidyl-inositol
(GPI) membrane anchored receptors such as aminopeptidase
N or alkaline phosphatase (Soberón et al., 2010). There is also
compelling evidence for ABC transporters serving as receptors
for Cry proteins in several lepidopteran species (Gahan et al.,
2010; Baxter et al., 2011; Atsumi et al., 2012). Receptor binding
is not suﬃcient to cause toxicity to the insect, as oligomeriza-
tion is required for pore formation (Federici and Siegel, 2008;
Soberón et al., 2010). The many permutations of species-speciﬁc
insect GI-tract proteases, receptors, and tendencies of each Cry
protein to oligomerize in a speciﬁc situation result in the bio-
logical speciﬁcity that provides targeted insecticidal activity and
safety to NTOs of Bt sprays and GM crops that produce Bt
proteins.
Receptor-Mediated Selectivity of Bt Cry
Proteins
An essential component of the highly selective insecticidal prop-
erties of most Cry proteins is the requirement that the toxin
interact with one or more speciﬁc receptors. Many studies have
demonstrated that the GI-tract epithelial surface of non-target
insects and mammals, including humans, lack speciﬁc high-
aﬃnity Cry protein receptors (Sacchi et al., 1986; Wolfersberger
et al., 1986; Hofmann et al., 1988a,b; Van Rie et al., 1989, 1990;
Noteborn et al., 1995; Lambert et al., 1996; Mendelsohn et al.,
2003; Griﬃtts et al., 2005; Shimada et al., 2006; OECD, 2007;
Vachon et al., 2012). The absence of high-aﬃnity binding in
mammals may be due in part to the absence of BL2, a glyco-
sylating enzyme present in the GI-tract cells of invertebrates.
This enzyme produces speciﬁc sugar residues that facilitate recog-
nition and binding by Cry proteins to the aminopeptidase N
and alkaline phosphatase receptors (Federici and Siegel, 2008;
Soberón et al., 2010).
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Experiments with surface plasmon resonance assays indicate
that binding to the cadherin receptor occurs at nM concentra-
tions (Sacchi et al., 1986; Hofmann et al., 1988a; Soberón et al.,
2010), which indicates relatively high aﬃnity, and is a charac-
teristic of a speciﬁc receptor-ligand relationship. The fact that
insecticidal LD50 is typically in the low ng/insect larva provides
additional evidence about the potency of Cry proteins in suscep-
tible insects that links Cry proteins and insect-speciﬁc receptors
(Federici and Siegel, 2008). Speciﬁcity of Cry protein binding
was shown with gut cell brush-border membrane vesicle (BBMV)
binding studies. In these experiments the binding of a labeled Cry
protein, which is active againstManduca sexta (Lepidoptera) lar-
vae, could be displaced by an unlabeled excess of the same Cry
protein or other Cry proteins active against M. sexta, but not by
Cry proteins with activity against dipteran or coleopteran larvae
(Hofmann et al., 1988b).
Extensive evidence has been accumulated on the mechanism
of action for Bt microbials, and Cry proteins in particular, and
resulted in a generally accepted model wherein Cry proteins bind
to speciﬁc high-aﬃnity receptors in the gut of target larval insects,
oligomerize, and form pores in the cellular membranes of the
gut. The result of pore formation is osmotic shock, cell lysis,
and eventual death of gut epithelial cells. Cadherin-like glycopro-
teins were mentioned above as receptors, but aminopeptidase N,
ABC transporters, and alkaline phosphatase have also been iden-
tiﬁed as Cry protein receptors, which enable pore formation in
target organisms. BL2 is a glycosylating enzyme found in tar-
get insect pests which is responsible for producing the speciﬁc
sugar residues that facilitate recognition and binding by Cry pro-
teins to the aminopeptidase N and alkaline phosphatase receptors
(Federici and Siegel, 2008; Hammond and Koch, 2012). The pres-
ence of this protein in insect species appears to contribute to the
taxonomic speciﬁcity of Cry proteins currently in Bt crops. The
absence of this protein is believed to be a reason why Cry pro-
teins fail to exhibit toxic eﬀects in mammals and other non-insect
species.
History of Safety Use of Bt Microbial
Products in Agriculture
There is an extensive history of safety for human consumption
of Cry proteins. Bt microbial pesticides have been used to con-
trol mosquito larvae in drinking water held in outdoor storage
facilities (WHO/IPCS, 1999; Bravo et al., 2007) and to con-
trol insect pests on organically grown vegetables (WHO/IPCS,
1999; Federici and Siegel, 2008). Frederiksen et al. (2006) found
levels of up to 104 CFUs (colony-forming units, i.e., viable Bt
microbes) per gram of plant tissue on fresh vegetables mar-
keted in Europe. The strains found were indistinguishable from
those in commercial Btmicrobial formulations, indicating that Bt
microbial applications were the likely source. Vegetables treated
with Bt (i.e., broccoli, tomatoes, cucumbers, cauliﬂower, and let-
tuce) are commonly eaten raw and may be minimally washed;
in such cases, people are directly consuming Cry proteins and
Bt spores with no apparent adverse eﬀects (Federici and Siegel,
2008).
Regulatory agencies have acknowledged the history of safe
consumption of Cry proteins. For example, the U.S. EPA (1998b)
stated, “The use patterns for Bacillus thuringiensis may result in
dietary exposure with possible residues of the bacterial spores
on raw agricultural commodities. However, in the absence of
any toxicological concerns, risk from the consumption of treated
commodities is not expected for both the general population and
infants and children.” Similarly, WHO/IPCS (1999) noted that
“Bt has not been reported to cause adverse eﬀects on human
health when present in drinking-water or food.” The lack of
adverse health eﬀects is further supported by an early test of
human safety, where no adverse eﬀects were reported when
volunteers were exposed to large doses of Bt spores: oral inges-
tion of 1010 Bt spores for 5 days or inhaled 109 Bt spores
(Siegel and Shadduck, 1990) and oral ingestion of Bt spores at
a dose of 1000 mg/day or inhalation of Bt spores at a dose of
100 mg/day for 5 days (Siegel, 2001). Because of their exceptional
safety proﬁle, Btmicrobials have historically been exempted from
the requirement for a numerical tolerance (maximum residue
level) in countries where they have been registered (OECD,
2007), meaning that there is no withdrawal time required for
consumption of crops sprayed with Bt microbials. Thus, the
safety of Bt microbials, including the Cry proteins, has been
well established through decades of use in various agricultural
applications around the world as recognized by international
health agencies (WHO/FAO, OECD, and numerous regulatory
agencies).
Human Dietary Exposure Assessment for Bt
Microbial Products
The potential human dietary exposure to Cry proteins from
application of commercial Bt microbial pesticide formulations
was recently estimated (Hammond and Koch, 2012; Box 1). The
adult intake of Cry protein from consumption of uncooked broc-
coli (heads) was estimated to be 1 μg/kg body weight for chronic
consumption [5]. This estimated exposure is several orders of
magnitude higher than a previous estimate of chronic dietary
intake of functionally active Cry protein from food derived
from GM maize expressing a Bt toxin Cry1Ab from a recombi-
nant gene inserted into the plant genome (∼0.008 μg/kg body
weight; Hammond and Jez, 2011; See Impact of Heat on Stability;
Box 2).
BOX 1 | Assumptions underlying estimation of human dietary exposure
to Cry proteins from Btmicrobial products (Hammond and Koch, 2012).
(1) The Btmicrobial formulation was applied to broccoli shortly before harvest.
(2) The commercial application rate for the Bt microbial formulation followed
the label directions from the supplier (up to 32 oz/acre).
(3) The Bt microbial formulation contained ∼10% Cry protein (w/w) and was
applied once.
(4) 10% of the applied Bt microbial formulation was deposited on broccoli
heads.
(5) Only broccoli heads were consumed.
(6) Broccoli consumption was set to the chronic dietary intake of broccoli in
the U.S. (8.2 gm/capita/day, Latté et al., 2011).
(7) The broccoli was consumed raw.
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BOX 2 | Assumptions underlying estimation of human chronic dietary
exposure to Cry1Ab protein from Bt maize (Hammond and Cockburn,
2008; Hammond and Jez, 2011).
(1) Corn is consumed at 50th percentile for adults in the UK (16 g/day).
(2) Level of Cry1Ab protein in unprocessed Cry1Ab maize grain is 0.3 ppm
(μg/g).
(3) Average adult body weight is 60 kg.
(4) All maize consumed is Cry1Ab maize.
(5) Thermal processing reduces functional activity by at least two orders of
magnitude.
The Use of Bt Cry Proteins in GM
Crops
Although Bt microbial preparations are safe and eﬃcacious, they
are limited in their duration of eﬀectiveness because they can
be washed oﬀ the plant (e.g., by rain) or inactivated by sunlight
within days after application (Federici and Siegel, 2008), and they
require considerable water, heat, and feedstock to produce, and
must be manually applied, either by hand sprayer on small plots
or by machine if applied to large tracts. These limitations have
been addressed through the introduction of GM crops containing
one or more genes encoding one or more Bt proteins, which are
produced by the plant throughout the growing season. Dietary
exposure to GM derived Bt proteins may be equal to or less than
that of Bt microbial products (See Impact of Heat on Stability).
Another advantage of GM crop products expressing Bt proteins
is that only the speciﬁc Bt protein(s) of interest, typically Cry pro-
teins, are produced in the crop, possibly decreasing the spectrum
of activity compared to Bt microbial formulations (Hammond
and Koch, 2012).
Most of the commercially approved Bt crops are corn and
cotton (Table 1). Recently, Bt soybean varieties expressing the
cry1Ac gene and Cry1Ac and Cry1F have been approved for
commercial use in Latin America to control lepidopteran pests
(CTNBio, 2010; EPA, 2010b, 2014), and Bt rice varieties with the
cry1Ab and Cry1Ac genes has been developed in China but initial
approval expired in 2014 (ISAAA, 2015).
Another type of modiﬁcation that has been used when devel-
oping a Bt Cry-containing GM crop is swapping portions or
whole domains from one Cry protein with portions or whole
domains from another Cry protein (Höfte and Whiteley, 1989;
Nakamura et al., 1990; Ge et al., 1991; Honée et al., 1991). Domain
swapping has been shown to be an eﬀective way to change the
spectrum of activity of a native Cry protein to include a new target
pest. Examples of proteins that have undergone domain swap-
ping for this purpose are Cry1A.105 and Cry1Ab/Ac; the former
is one of a series of modiﬁed proteins that exhibit improved activ-
ity toward fall armyworm larvae but otherwise retained speciﬁcity
toward other target lepidopteran pest species (Malvar et al., 2004).
Such domain exchanges are possible, in part, because the tertiary
structures of these Cry domains are highly conserved (Li et al.,
1991; Grochulski et al., 1995; Derbyshire et al., 2001; Galitsky
et al., 2001). As another example, the Cry1Fa-like protein in
the Bt microbial Lepinox (construct 11724) contains the core
Cry1Fa insecticidal protein moiety fused to a Cry1Ac C-terminal
TABLE 1 | Bt Cry proteins in GM crops authorized for cultivation in one or
more countries.
Protein Insect
type
controlled
Crop
species
approveda
Examples of
productsb
(Registrant)
Cry1Ab Lepidoptera Maize YieldGard (Monsanto)
Agrisure CB/LL
(Syngenta)
Cry1Ac Lepidoptera Cotton Bollgard (Monsanto)
Maizec Bt Xtra (Monsanto)
Soy Intacta Roundup Ready
2 Pro (Monsanto)
Brinjal BARI Bt Begun-1, -2,
-3, -4 (MAHYCO)
Cry1A.105 + Cry2Ab2 Lepidoptera Maize Genuity VT Double Pro
(Monsanto)
Cry1Ac + Cry2Ab2 Lepidoptera Cotton Bollgard II (Monsanto)
Cry1Ac + Cry1F Lepidoptera Cotton WideStrike (Dow)
Soy DAS-81419-2 (Dow)
Cry1Fa2 Lepidoptera Maize Herculex I (Dow)
Cry1Ab + Cry2Ae Lepidoptera Cotton TwinLink (Bayer)
mCry3A Coleoptera Maize Agrisure RW (Syngenta)
Cry3Bb1 Coleoptera Maize YieldGard Rootworm
RW (Monsanto)
eCry3.1Abd Multiple Maize Agrisure Duracade
(Syngenta)
Cry34Ab1 + Cry35Ab1 Coleoptera Maize Herculex RW (Dow and
DuPont)
Data from http://www.isaaa.org/gmapprovaldatabase/
aApproval does not mean that crops were planted commercially or are still being
planted.
bNot all products and combinations are listed.
cWith pinII (protease inhibitor) from Solanum tuberosum.
dChimeric Cry3A–Cry1Ab protein.
protoxin moiety (Baum et al., 1999). This modiﬁed protein exhib-
ited improved expression in Bt but retained the insecticidal
speciﬁcity of the native Cry1Fa protein (Gilmer and Baum, 1999).
Recently, the chimeric eCry3.1Ab insecticidal protein was devel-
oped to provide protection against root feeding damage caused
by the western corn rootworm, northern corn rootworm, and
Mexican corn rootworm. The eCry3.1Ab protein is composed of
domains I, II, and a portion of domain III of the native Cry3A
protein and the C-terminus of the Cry1Ab protein (Walters et al.,
2010; EPA, 2013).
There are several important, well-established examples that
demonstrate that small changes in Bt amino acid sequence do
not change the safety proﬁle for NTOs. Regulatory authorities
have required functional studies with sensitive insect bioassays
to demonstrate that these small changes do not impact biologi-
cal activity. If these assays indicate biological activity equivalence
of the two protein forms, any other properties of the proteins
are considered to be equivalent as well. Consequently, it is not
necessary to repeat all of the assays performed for the original
safety assessment; regulators will consider “bridging” to the form
of the protein that was used for the environmental safety test-
ing. A well-established example of this approach was used to
bridge the existing safety assessment performed for the Cry3Bb1
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protein produced by MON863 maize to support the approval of
MON88017 maize, which also produces a variant of the Cry3Bb1
protein. The Cry3Bb1 protein expressed in MON88017 maize
is functionally and physicochemically similar to that expressed
in MON863 maize. The proteins diﬀer by only 1 amino acid
out of 653 (99.8% homology) and are expressed at comparable
levels in the plant. To test for functional equivalence, sensitive
insect diet incorporation bioassays were performed with appro-
priate insect models (i.e., Colorado potato beetle and western
corn rootworm) to estimate LC50 values. The results were simi-
lar for both Cry3Bb1 variants (EPA, 2010c). Another example is
the form of the Cry2Ab2 protein produced by MON15985 cotton
and MON89034 maize. These two forms of the Cry2Ab2 protein
diﬀer by a few amino acids on the N-terminus of the proteins
and reﬂect the introduction of a chloroplast transit peptide (EPA,
2010a). Despite the addition of these amino acids, there was no
impact on biological activity in a sensitive insect bioassay (EPA,
2010a).
Critics have raised safety concerns about modiﬁcations that
have been made to Bt Cry proteins introduced into GM crops.
They consider the modiﬁed Cry proteins as not “natural,” argu-
ing that their safety is unknown and they should be subjected
to chronic animal testing as is done for small-molecule chem-
ical pesticides (Séralini et al., 2011). There are two problems
with this rationale. First, whether or not a substance is “natu-
ral” has very little to do with its intrinsic safety [e.g., α-latrotoxin
occurs naturally in spiders of the genus Latrodectus, and is quite
lethal in very small amounts – the LD50 in mice is 20–40 μg/kg
(Ushkaryov et al., 2004)]. Rather, the focus should be on whether
the modiﬁcations fundamentally alter the structure and func-
tional properties of the protein to a degree that it aﬀects the safety
of these proteins (See History of Safe Use and Bioinformatics).
Thus, despite the changes introduced, the extensive history of
safe human consumption of native Cry proteins can be applied
to the safety assessment of these modiﬁed proteins (Hammond
et al., 2013). Second, Bt Cry proteins in either their microbial
or plant-incorporated protectant (i.e., GM crops) form are classi-
ﬁed as biopesticides by the U.S. EPA (2015). This is an important
designation because biopesticides are generally considered be
inherently less toxic and have a narrower spectrum of activity
(i.e., aﬀect only the target pest and closely related organisms)
than conventional pesticides (EPA, 2015). Accordingly, the cur-
rent testing paradigm is suﬃcient for detecting potential hazards
associated with GM crops; especially, when considered with the
Weight of Evidence accumulated from the analyses subsequently
detailed in Section “Food Safety Assessment of Cry Proteins
Introduced into Bt Crops” and its subsections.
Food Safety Assessment of Cry
Proteins Introduced into Bt Crops
Several International Life Sciences Institute (ILSI) task forces
have examined and provided science-based recommendations for
the safety assessment of crops derived from agricultural biotech-
nology. Principles for the assessment of proteins used in agri-
cultural biotechnology were described in detail by Delaney et al.
(2008) and revisited and expanded by Hammond et al. (2013).
Both describe a two-tiered approach of hazard identiﬁcation fol-
lowed by hazard characterization appropriate to the identiﬁed
hazards, if any. Regulatory guidance on the assessment of insecti-
cidal proteins has been given by both national and international
authorities (Mendelsohn et al., 2003; Codex Alimentarius, 2009;
EFSA, 2011).
History of Safe Use and Bioinformatics
One of the steps in initial (“Tier I”) evaluation of a protein is to
examine its history of safe use (HOSU). As discussed in Section
“The Use of Bt Cry Proteins in GM Crops,” some Bt proteins are
modiﬁed from their native form for use in GM crops; thus, it is
important to consider whether the HOSU of one protein can be
applied to related proteins (Hammond et al., 2013).
Although there are seemingly an unlimited number of changes
that could be made to improve protein function, one estimate
indicates that only 0.01–0.5% of random amino acid sequence
modiﬁcations are beneﬁcial (Bloom and Arnold, 2009). Looking
further into the types of changes that a protein can undergo
can help explain this estimate. Substitution of one amino acid
residuewith another one of similar size and properties might have
little eﬀect; on the other hand, substitutions that alter the three-
dimensional structure will likely have major deleterious conse-
quences on protein functionality. Modiﬁcations that alter the
ability of the protein to fold properly are often deleterious because
they reduce or eliminate the functional activity. Although radical
changes are possible, amino acid sequence modiﬁcations intro-
duced in engineered proteins are normally designed to enhance
function with minimal disruption of structure. By retaining the
three-dimensional structure of the naturally occurring protein,
the general functional characteristics are also preserved in the
engineered protein (Behe et al., 1991; Lattman and Rose, 1993;
Rose and Creamer, 1994). This is also true for most evolutionary
changes because the structure and function of an essential protein
must be conserved (Illergård et al., 2009).
When in vitro engineering introduces minor changes to the
structure or function of a protein, there is little reason to sug-
gest that the engineered protein will become toxic. This has been
the case for evolutionary changes within protein families such
as those used as food processing enzymes. These changes have
not resulted in the enzymes becoming toxic to humans (Pariza
and Cook, 2010). As an example of how diﬃcult it is for a set of
speciﬁc mutations to convert a non-toxic protein into one that
is toxic, Pariza and Cook (2010) calculated that the probability
that nine amino acid substitutions could make a non-toxic pro-
tein into a known protein toxin was only 1 in 2 × 1011. For
context, this is similar to selecting a speciﬁc drop of water in
one of ﬁve Olympic-sized swimming pools on the ﬁrst attempt.
As illustrated by the speciﬁcity of Cry proteins for their target
insects (See Receptor-Mediated Selectivity of Bt Cry Proteins),
the eﬀects of protein toxins in susceptible organisms generally
depend on recognition of speciﬁc molecular targets (Rappuoli
and Montecucco, 1997).
In addition to considering the HOSU of related proteins, per-
forming bioinformatic analyses of protein sequence and structure
can provide valuable information on the safety of a modiﬁed Cry
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protein or other introduced protein. A bioinformatics evaluation
is performed as one of the initial steps in the Tier 1 safety assess-
ment (Delaney et al., 2008). These comparisons of the candidate
protein to sequence and structure databases are used to deter-
mine whether the protein of interest is similar to any known toxic
protein. Analyses of phylogenetic relationships between the can-
didate protein and others are also useful (Codex Alimentarius,
2009; EFSA, 2010e, 2011; Hammond et al., 2013) because high
similarity may indicate a conserved function (e.g., Mills et al.,
2004).
Human Dietary Exposure Assessment for
Cry Proteins in Bt Crops
The information gathered from the safety assessments described
throughout this manuscript identiﬁes if there is a potential hazard
associated with the Cry proteins and are necessary for performing
dietary risk assessments. However, a determination of exposure
is also required because risk is a function of both hazard and
exposure (Faustman and Omenn, 2008).
An estimate of the maximum potential exposure to a Cry pro-
tein through the diet can be derived by determining the protein
expression level in the grain and the amount of grain consumed.
Such values are highly conservative estimates of dietary exposure
because they do not account for the lack of stability of the pro-
tein during digestion, they do not consider its response to heat
or food processing conditions, they ignore that commodity crops
are a blend of multiple varieties (i.e., all the crop consumed is
presumed to be the variety in question), and they often utilize
very high consumption levels (i.e., 97.5th percentile “Eater-Only”
values). The harsh conditions encountered by dietary proteins in
the GI lumen and during food production processes signiﬁcantly
reduce their stability as detailed below.
Impact of Protein Digestibility
Most ingested dietary proteins undergo hydrolytic digestion
and/or degradation (Delaney et al., 2008). To approximate the
eﬀects of protein exposure to conditions in the mammalian GI
tract, a validated in vitro assay to assess the potential stability
of proteins to pepsin digestion has been developed. This reli-
able and reproducible assay uses a ﬁxed pepsin:protein ratio and
low pH (pH 1.2 and 2.0; Thomas et al., 2004). Cry proteins
are readily degraded in this assay (EPA, 2001; Okunuki et al.,
2002; Herman et al., 2003; Thomas et al., 2004; Cao et al., 2010;
Guimaraes et al., 2010). Under conditions of higher pH and lower
ratios of pepsin to Cry protein, Cry1Ab protein is more slowly
degraded, as is expected since pepsin becomes less active at a
greater pH (Guimaraes et al., 2010). Although Guimaraes et al.
(2010) suggest that the current low-pH test may need to be revis-
ited, Ofori-Anti et al. (2008) reported that, as anticipated based
on classic enzymology, varying pH, and pepsin concentration had
only small eﬀects on digestion of proteins of intermediate stabil-
ity to pepsin and no eﬀects on proteins that are either stable in
the presence of pepsin or rapidly digested by pepsin.
In pigs and calves, Cry protein fragments are detectable but
are progressively reduced in size as they travel down the GI
tract. None were detected in the liver, spleen, or lymph nodes
(Chowdhury et al., 2003a,b) indicating they were too large to be
systemically absorbed from the GI tract. It has been suggested that
transgenic nucleic acids and proteins from GM crops are handled
in the gut like their conventional counterparts, with no evidence
for systemic absorption of intact proteins or genes (S´wia˛tkiewicz
et al., 2009; Walsh et al., 2012a,b; Sieradzki et al., 2013). It is
notable that farm animals generally have a much higher propor-
tion of maize in their diets than humans; for example, in the
case of broiler chickens, maize accounts for approximately 65% of
their diet throughout their productive lifetime. In addition, maize
fed to animals is generally not processed, other than grinding.
Human dietary exposure to Cry proteins is much lower than that
of farm animals owing to the lower percentage of maize in the diet
and the processing (e.g., cooking) used to prepare most human
food containing maize. As described in the following Section
“Impact of Heat on Stability,” thermal processing denatures Cry
proteins, causing them to lose insecticidal activity (Table 2) and
making themmore susceptible to protease degradation (Okunuki
et al., 2002; Herman et al., 2006). Recalling that risk is a function
of both hazard and exposure, the lower exposure encountered by
humans puts them at lower risk than animals. This is particularly
noteworthy when one considers that the animals did not demon-
strate reliable signs of toxicity (i.e., no hazard was identiﬁed)
following the consumption of GM crops, despite considerably
higher dietary exposure.
Impact of Heat on Stability
Prior to human consumption, Cry proteins in GM crops typi-
cally undergo some sort of thermal processing, which must be
considered in the toxicological safety assessment because it can
signiﬁcantly reduce the dietary exposure to functionally active
Cry protein. Temperature increases, pH variation, and physical
disruption can overcome the forces that keep a protein folded
properly (Creighton, 1993) and cause denaturation, i.e., changes
in protein secondary, tertiary, or quaternary structure. Because of
the change in three-dimensional structure, denatured polypep-
tides lose functional activity, including the ability to speciﬁcally
bind receptors or other compounds.
A number of Cry proteins have been subjected to in vitro
heat stability studies under conditions similar to those used for
human food processing (Hammond and Jez, 2011; Table 2). All
Cry proteins tested except Cry9C, which was modiﬁed by its
developer for enhanced stability (Center for Environmental Risk
Assessment, 2001), lost insecticidal activity or immunodetectabil-
ity after processing (Table 2). The impact of food processing on
the functional activity of introduced proteins is relevant because
for cooked food, it results in safety margins that are conser-
vative and an overestimate of actual exposure (i.e., the dietary
exposure estimates do not typically include the eﬀects of process-
ing on exposure). The European Food Safety Authority (EFSA
GMO Panel Working Group on Animal Feeding Trials, 2008)
agrees that the eﬀects of food processing may result, “. . .in over-
estimated exposure levels and even larger margins of safety for
man.” It has been estimated that when using heat denaturation
studies the levels of functionally active protein introduced into a
GM crop can be reduced by approximately two orders of mag-
nitude (100-fold) when the crop is processed (e.g., by cooking;
Hammond and Jez, 2011).
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TABLE 2 | Impact of heating and food processing on Cry proteins.
Introduced protein In vitro heat Functional activity/Immunodetectability Reference
Cry1Ab 80◦C; 10 min Insect bioassay – loss of activity de Luis et al. (2009)
Cry1F 75–90◦C; 30 min Insect bioassay – loss of activity EFSA (2005c)
Cry9C 90◦C; 10 min Insect bioassay – No loss of activity de Luis et al. (2009)
Cry34Ab1, Cry35Ab1 60–90◦C; 30 min Insect bioassay – loss of activity EFSA (2007)
eCry3.lAb 95◦C; 30 min Insect bioassay – loss of activity EPA (2013)
Cry1A.105 204◦C; 20 min No immunodetectability EPA (2010a)
Cry2Ab2 204◦C; 20 min No immunodetectability EPA (2010a)
Cry1Ac Not stated in Biopesticides
Registration Action Document
No immunodetectability EPA (2010b)
After Hammond et al. (2013)
For Bt maize containing diﬀerent Cry proteins, the levels
of Cry proteins in grain were approximately 0.3–0.7 ppm for
Cry1Ab and approximately 15–115 ppm for other Cry pro-
teins (Hammond and Cockburn, 2008). Using the conserva-
tive assumptions detailed in Section “Human Dietary Exposure
Assessment for Cry Proteins in Bt Crops” for human dietary
exposures (Hammond and Jez, 2011), the potential human
dietary intake of functionally active Cry protein from Bt maize
could range from 0.008 to 2 μg/kg body weight [BW]/day
(Hammond and Koch, 2012). Even these values may overesti-
mate exposure, as the calculation for exposure to Cry1Ab Bt
protein in Hammond and Jez (2011) of 0.008 μg/kg BW appears
to reﬂect only a 10-fold reduction in activity caused by cook-
ing (vs. the intended 100-fold reduction). Thus, dietary exposure
from Bt crops may be similar to or even less than dietary exposure
from vegetables treated with Bt microbial formulations shortly
before harvest (estimated in Section “Human Dietary Exposure
Assessment for BtMicrobial Products”).
Clearly, digestion and food processing greatly limit the dietary
exposure of any proteins consumed orally whether transgenic
or endogenous. Nonetheless, companies seeking registration of
biotech crops often use the highly conservative approach of
estimating exposure by determining the protein expression in
the grain and multiplying it by the amount of grain con-
sumed. This obviously overestimates exposure for the reasons
detailed above. Despite this conservative approach in estimat-
ing dietary exposure (i.e., over-estimating dietary exposure), it
has still been possible to achieve very large margins of exposure
between the levels of Cry proteins safely administered to ani-
mals and conservative estimates of human intake (Juberg et al.,
2009).
Allergy Safety Assessment of Cry Proteins
The allergy assessment of a GM crop is designed to identify
potential allergenic risks associated with an introduced protein
(Codex Alimentarius, 2009). A weight-of-evidence approach is
taken to assess the allergenic potential of the introduced pro-
tein. This assessment includes determining whether the source
organism of the introduced protein is allergenic, an extensive
bioinformatics assessment to determine if the introduced pro-
tein is similar to known allergens, and determining the level
of exposure of the introduced protein in the GM crop, includ-
ing determining the stability of the protein to digestive enzymes
(Goodman et al., 2005; Lehrer and Bannon, 2005; Bannon and
Martino-Catt, 2007).
Bacillus thuringiensis microbials are not considered a human
allergen, because despite the extensive use as a biopesticide over
the last several decades, there has been only one report of aller-
gic reactions in workers who manufacture or apply Bt microbials
(Siegel, 2001; Federici and Siegel, 2008). However, this single
allergic reaction was attributed to bacterial proteins in the Bt
microbial formulation other than the Cry proteins (Siegel, 2001;
Federici and Siegel, 2008). None of the Bt Cry proteins used to
develop GM crops have had any sequence similarity to known
human allergens using any of the bioinformatics thresholds for
amino acid similarity recommended by international guidance
(Codex Alimentarius, 2009; Silvanovich et al., 2009).
Another assessment of allergenic potential of the inserted pro-
tein is to determine the exposure to the protein. This is relevant to
the allergenicity assessment because it is generally accepted that
increased exposure to a protein increases the possibility that the
protein could become an allergen. Exposure is assessed by mea-
suring the protein abundance in the grain (See Impact of Heat
on Stability) and the stability of the protein in the presence of
pepsin (See Impact of Protein Digestibility). Unlike the toxicolog-
ical safety assessment, the heat stability assessment of the protein
does not provide useful information to the allergy safety assess-
ment because an allergen does not need to be in a functional
state to cause an allergic reaction (Privalle et al., 2011). Although
pepsin resistance aﬀects the potential exposure to the introduced
protein, it is important to point out there is evidence that some
allergens are present in high levels in food crops and/or resis-
tant to digestion, but there are also non-allergenic proteins that
have these same properties (Fu et al., 2002). For this reason, it
is important to recognize that these analyses are not predictive
of allergenic potential, but instead should be considered as part
of the weight-of-evidence approach. Taken together, the weight-
of-evidence approach used to assess the Cry proteins present in
Bt crops suggests the allergenic potential of these proteins is low
and that they present little allergenic risk.
Acute and Short-Term Mammalian
Toxicology Testing of Bt Cry Proteins
In the paradigms outlined byDelaney et al. (2008) and Hammond
et al. (2013) and introduced earlier in this manuscript, Tier II
studies such as toxicology testing are only warranted when a
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potential hazard has been identiﬁed in Tier I. Acute toxicology
testing was originally warranted because of the insecticidal (i.e.,
toxic) acute mode of action of Cry proteins. As described in sub-
sequent sections, neither short- nor long-term toxicology testing
has revealed any concerns about the safety of Bt proteins for
human or animal consumption.
In general, there are fundamental biological properties of pro-
teins that greatly limit their potential to produce chronic toxic
eﬀects when ingested (Delaney et al., 2008; Hammond et al.,
2013). These properties are discussed in detail in Hammond et al.
(2013) and some of the key points are summarized here:
(1) Protein macromolecules are degraded by the digestive
enzymes of the GI tract into small peptides and individual
amino acids to facilitate absorption. Furthermore, it is gen-
erally known that there is an inverse relationship between
molecule size and absorption [smaller molecules are more
readily absorbed intact than larger ones (Gardner, 1988)].
Consequently, the potential for absorption of an intact pro-
tein from the GI tract is much lower than a low molecular-
weight chemical.
(2) Multiple and redundant barriers restrict the movement of
intact proteins into cells after dietary consumption (Kier and
Petrick, 2008). With the exception of nursing newborns, a
primary barrier in humans is the plasma membrane of GI
tract epithelium. These membranes contain receptors and
transporters that enable the intact uptake of speciﬁc pro-
teins, but are otherwise impermeable to exogenous proteins
(Gardner, 1988). Repeated failures to develop orally adminis-
tered protein-based therapeutics (O’Hagan et al., 1988; Shah
et al., 2002; Goldberg and Gomez-Orellana, 2003; Hamman
et al., 2005) demonstrate the eﬀectiveness of these barriers.
(3) The ingestion of proteins has not been shown to be carcino-
genic, teratogenic, or mutagenic (Pariza and Foster, 1983;
EPA, 2000; Pariza and Johnson, 2001), and the proteins
introduced to date into GM crops are not considered to be
toxic based on their known biochemical function and on the
results obtained from bioinformatics searches.
(4) Based on the biochemical functions of known protein toxins,
toxicity is usually manifest after acute or short-term dietary
exposure. Additionally, there is no example of a protein that
bioaccumulates with chronic dietary intake. Instead, pro-
teins are degraded to amino acids that are reassembled into
new proteins. There are no storage proteins in animals and
humans; rather, energy is stored as adipose tissue, which is
biochemically distinct from protein. Thus, chronic testing is
unlikely to add meaningfully to the safety assessment of GM
crops.
Considering the ﬁrst two points above, and that Cry proteins
are readily digested (See Impact of Protein Digestibility) and can
be denatured and inactivated during normal food processing (See
Impact of Heat on Stability), human dietary exposure to function-
ally active dietary proteins, including Cry proteins, is likely to be
negligible.
The U.S. EPA (2000) requires the use of high-dose (gram/kg
BW) acute testing for Cry proteins where feasible because they
act through an acute mode of action to kill insect pests (Sjoblad
et al., 1992; Delaney et al., 2008). While acute oral toxicity stud-
ies with proteins from GM crops have fallen out of favor in
some world areas (e.g., the EU), they are still commonly con-
ducted as part of the safety assessment in other world areas
(e.g., China). Current acute oral toxicity study designs may be
adapted from relevant guidance in OECD Guidelines for the
Testing of Chemicals (i.e., OECD Test Guidelines 420, 423,
and 425). It has not always been possible to achieve gram/kg
dosage levels because of the limited solubility of some Cry pro-
teins in dosing vehicles (McClintock et al., 1995; Betz et al.,
2000); nevertheless, the dosages administered to date have still
been many orders of magnitude higher than any dose that
humans might potentially encounter in the diet. Recently, EFSA
(2011) stated that they may require a repeat-dose 28-day toxi-
cology study when it considers the available safety information
on the introduced protein to be insuﬃcient. What this means
in practice has not yet been determined for Cry proteins, but
given the substantial HOSU of Cry proteins and the existing
weight of evidence for approved traits, there should be suﬃ-
cient scientiﬁc evidence on the safety of such proteins to preclude
the need for conducting a 28-day study. This is particularly
important when one considers the scientiﬁc community’s obli-
gation to reduce, replace, and reﬁne animal studies when sci-
entiﬁcally feasible, and the fact that such studies are unethical
when they provide little additional information of value to risk
assessment (See Whole Food Animal Feeding Studies with Bt
Crops).
Table 3 presents the no-observed-adverse-eﬀect levels
(NOAEL) for a variety of Cry proteins and Bt microbials fed to
mice in acute toxicity studies at doses 1000s to 1,000,000s of times
higher than the doses that are acutely toxic to the target insects
(Hammond and Cockburn, 2008). A good way to illustrate this
disparity is to consider an extreme example. To attain the same
acute dose of Cry1Ab protein as that administered to mice with
no adverse eﬀects (4000 mg/kg/day; Table 3), an adult human
would have to consume approximately 900,000 kg of uncooked
Bt maize grain in 1 day (Hammond and Cockburn, 2008). This
amount of shelled corn would be the equivalent of 35 semi-truck
loads. Thus, these data represent a considerable weight of
evidence that Cry proteins are safe for consumption as food and
feed; especially when considered with the safety of microbial Bt
pesticides (See History of Safety Use of Bt Microbial Products in
Agriculture); as well as bioinformatics (See History of Safe Use
and Bioinformatics), in vitro digestibility assays (See Impact of
Protein Digestibility), low dietary exposure levels (See Human
Dietary Exposure Assessment for Bt Microbial Products), and
the absence of toxicity following high dose acute studies (See
Acute and Short-Term Mammalian Toxicology Testing of Bt Cry
Proteins) with the Cry proteins tested to-date.
Assessment of Issues Raised
Concerning Cry Proteins
This section will discuss in detail the technical deﬁciencies of
some of the papers that report potential health concerns with Bt
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TABLE 3 | Acute toxicity studies in mice with Cry proteins and Bt
microbials.
Test substance NOAELa Reference
Cry protein
Cry1Ab 4000 mg/kg Betz et al. (2000)
Cry1Ab/Cry1Ac fusion protein 5000 mg/kg Xu et al. (2009)
Cry1A.105 2072 mg/kg EPA (2010a)
Cry 1Ac 4200 mg/kg Betz et al. (2000)
Cry1C 5000 mg/kg Cao et al. (2010)
Cry2Aa 4011 mg/kg Betz et al. (2000)
Cry2Ab 1450 mg/kg Betz et al. (2000)
Cry2Ab2 2198 mg/kg EPA (2010a)
Cry3A 5220 mg/kg Betz et al. (2000)
Cry3Bb 3780 mg/kg Betz et al. (2000)
Cry1F 576 mg/kg EPA (2001)
Cry34Ab1 2700 mg/kg Juberg et al. (2009)
Cry35Ab1 1850 mg/kg Juberg et al. (2009)
eCry3.1Ab 2000 mg/kg EPA (2013)
Bt microbial product
Cry1Ac, Cry2A, Cry1C Btk
Crymax
>108 CFUb/rat Betz et al. (2000)
Cry1Aa, Cry1Ac, Cry2A,
Cry1Fa/1Ac Btk Lepinox 11724
>108 CFU/rat Betz et al. (2000)
Cry4A, Cry4B, Cry10A &11A,
Cry11
>1011 CFU/rat Betz et al. (2000)
Cry3Aa Bti Teknar 5050 mg/kg Betz et al. (2000)
aHighest dosage tested that caused no adverse effects.
bColony-forming units.
After Hammond and Cockburn (2008).
microbials or Cry proteins. It will also examine the reasons that,
despite past practices, long-term animal testing with Bt crops is
not scientiﬁcally beneﬁcial or justiﬁed.
Despite the considerable history of safe consumption, and the
large volume of data demonstrating the safety of both Bt for-
mulations and Cry proteins, some parties still doubt the safety
of these products. Occasional publications will make startling
claims: for example, some claim that Bt toxins can increase aller-
genic potential, or cause hematotoxic reactions, or represent an
uncharacterized risk to pregnant mothers. Yet upon closer exam-
ination, these allegations do not appear to have a strong scientiﬁc
basis.
When one considers the overall demonstrated safety of Cry
proteins and the lower dietary exposure to Bt proteins from con-
sumption of a GM crop than microbial Bt formulations used in
conventional and organic agriculture, claims of adverse eﬀects
exclusively following the consumption of Bt crops simply do not
withstand closer scrutiny.
Whole Food Animal Feeding Studies with Bt
Crops
There is a long safety history of Bt microbial pesticides on agri-
cultural crops (See History of Safety Use of BtMicrobial Products
in Agriculture), and there is similarly a HOSU of Bt crops since
1996 when these crops were ﬁrst introduced into commerce.
Following review of relevant data in submitted dossiers from
registrants, the U.S. FDA and EPA have not, to date, considered
additional animal toxicology studies with whole foods (i.e., GM
corn grain or soy meal) as necessary to conﬁrm safety. Rather,
they have considered the weight of evidence comprised in part
by HOSU, the demonstrated safety of the trait in mammals (i.e.,
acute and subchronic toxicity testing results), and compositional
and agronomic tests to come to address unintended eﬀects and
come to the conclusion that Bt crops are as safe as their conven-
tional comparators. However, 90-day rodent subchronic feeding
studies with whole foods were often required by some coun-
tries in the EU to conﬁrm the safety of the ﬁrst generation of
Bt crops (Table 4). Additional repeat-dose toxicology studies
that have been conducted for other purposes are also summa-
rized in Table 4 including reproduction and chronic studies on
Bt crops as well as feeding studies on commercial Bt microbial
formulations (see also Bartholomaeus et al., 2013).
To test whether GI impairment would alter the potential tox-
icity of Cry1Ab protein, Onose et al. (2008) used a subchronic
GI impairment rat model. Rats were treated with famotidine
(to reduce gastric acid secretion) and indomethacin (to damage
the intestinal epithelium) and fed diets with or without Cry1Ab
protein (10 ppm). Despite the expectation of less Cry1Ab pro-
tein digestion and more absorption of Cry1Ab protein into the
circulatory system of the GI-impaired animals, there was no
evidence of meaningful toxicological eﬀects (changes in clinical
blood parameters and histologic appearance of organs) in the
Cry1Ab-dosed animals.
There have also been a few multigeneration reproduction
studies carried out with animals fed Bt crops (Table 4). There
were no treatment-related adverse eﬀects seen on reproduc-
tive performance in animals fed Bt crops or other transgenic
crops (Snell et al., 2012). While there were occasional diﬀerences
observed between control and treated animals in blood param-
eters and organ weights, none were considered to be treatment
related, consistent with the weight of evidence of numerous sub-
chronic animal studies that have been carried out with a variety
of diﬀerent Bt crops (Table 3). One reproduction study (Kiliç
and Akay, 2008) reported minor histologic ﬁndings in the rats
fed Bt maize, but these ﬁndings were not consistent with the
weight of evidence of many other subchronic rat studies where
no evidence of treatment-related histologic changes have been
reported.
EFSA GMO Panel Working Group on Animal Feeding Trials
(2008) published a review article that included their assessment
of a number of published toxicology studies that had been con-
ducted on GM crops (Bt and non-Bt). According to the review,
the majority of these studies showed no adverse eﬀects. EFSA
GMO Panel Working Group on Animal Feeding Trials (2008)
reported that while some studies reported adverse eﬀects in
animals, deﬁciencies in these studies made the results uninter-
pretable. As a result, these studies should not be used to inform
the risk assessment process for these crops. Similarly, indepen-
dent researchers reviewed 24 long-term or multigenerational
studies with GM crops and came to the conclusion, “. . .GM
plants are nutritionally equivalent to their non-GM counterparts
and can be safely used in food and feed” (Snell et al., 2012).
The issues surrounding whole food testing of GM crops (Bt and
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TABLE 4 | Examples of repeat-dose toxicity studies with Bt microbial formulations, Cry proteins, and Bt crops.
Test article Dose/dietary level Study type and test animal Reference
Bt microbial formulation
DIPEL Bt microbial 8400 mg/kg 90-day rat Betz et al. (2000)
DIPEL Bt microbial 8400 mg/kg 2-year rat Betz et al. (2000)
TEKNAR Bt microbial 4000 mg/kg 90-day rat Betz et al. (2000)
Berliner Bt microbial 1000 mg/adult 5-day (human) Betz et al. (2000)
Cry protein
Cry34Ab1 and Cry35Ab1 (CRW) 205 mg/kg 4-week mouse Juberg et al. (2009)
Bt crop
Bt tomato 10% in dieta 90-day rat Noteborn et al. (1995)
Bt/HTb maize(ECBc/RRd ) 11/33% in dieta 90-day rat EFSA (2005d)
Bt/HT maize(CRWe/RR) 11/33% in dieta 90-day rat EFSA (2005e)
Bt/HT maize(ECB/CRW/RR) 11/33% in dieta 90-day rat EFSA (2005b)
Bt maize(ECB/CRW) 11/33% in dieta 90-day rat EFSA (2005a)
Bt maize (ECB) 11/33% in dieta 90-day rat Hammond et al. (2006b)
Bt maize (CRW) 11/33% in dieta 90-day rat Hammond et al. (2006a)
Bt maize (ECB) 11/13% in dieta 90-day rat MacKenzie et al. (2007)
Bt cotton 10% in dieta 90-day rat Dryzga et al. (2007)
Bt rice 60% in dieta 90-day rat Schrøder et al. (2007)
Bt/HT maize(CRW/Gluff ) 35% in dieta 90-day rat Malley et al. (2007)
Bt/HT maize(CRW/RR) 11/33% in dieta 90-day rat Healy et al. (2008)
Bt maize (CRW) 50/70% in dieta 90-day rat He et al. (2008)
Bt/HT maize(ECB/CRW) 34% in dieta 90-day rat Appenzeller et al. (2009)
Bt rice (Cry1Ab/Cry1Ac) 60% in dieta 90-day rat Wang et al. (2013)
Bt rice (Cry1Ac) 73–82% in dieta 78-week rat Zhang et al. (2014)
Multigenerational studies
Bt maize (ECB) 68% in dieta 5-generation rat Haryu et al. (2009)
Bt maize (ECB) 20% in dieta 3-generation rat reproduction Kiliç and Akay (2008)
aPercent (w/w) maize, rice, or cottonseed meal added to the diet.
bHT, herbicide tolerant.
cECB, European corn borer.
dRR, Roundup Ready R© (tolerant to glyphosate herbicide).
eCRW, corn rootworm.
fGluf, glufosinate (tolerant to glufosinate herbicide).
non-Bt) have recently been examined by two groups of authors
(Bartholomaeus et al., 2013; Kuiper et al., 2013). Considering the
limitations of whole food testing, such as low sensitivity and dif-
ﬁculty in deﬁning the test material, both groups concluded that
routine whole food testing does not add meaningful information
to the risk assessment of GM crops and cannot be scientiﬁcally
justiﬁed.
Another recent review article evaluated the reliability of a
number of the published toxicology studies carried out with GM
crops and proteins in general, and Cry proteins and Bt crops
in speciﬁc, by adapting the ToxRTool (Koch et al., 2014). The
ToxRTool was originally developed to objectively assess the reli-
ability of published toxicology studies on chemicals for the pro-
gram on Registration, Evaluation, Authorization, and Restriction
of Chemicals (REACH) in Europe. When its objective criteria
were adapted for feeding studies and used to evaluate studies with
Bt crops most of the studies were considered to be reliable. Of
the studies determined to be reliable, none found evidence of
adverse eﬀects from the consumption of GM crops containing
Cry proteins or of puriﬁed Cry proteins (Koch et al., 2014).
Adjuvanticity
Other papers have reported that Cry proteins, present in both Bt
microbial formulations and GM crops, stimulate IgG, IgM, and
IgA antibody production following intraperitoneal (IP), intra-
gastric (IG), intranasal (IN), or intra-rectal (IR) administration
(Vázquez-Padrón et al., 1999a,b, 2000a,b; Moreno-Fierros et al.,
2000).
The biological relevance of these studies to assessing poten-
tial health risks from human consumption of foods derived from
Bt crops is limited because administration of Cry proteins by IN,
IP and IR routes of exposure do not predict risks from IG or
dietary intake. IN, IP, and IR routes of exposure bypass the pro-
tective barriers of the GI tract and are not particularly relevant
when characterizing hazards that might be associated with a pro-
tein that will be consumed as food. However, when an IG route
of exposure was used, it was necessary to include a magnesium–
aluminum hydroxide suspension to see an eﬀect on these studies.
This anti-acid suspension was used to neutralize the pH of the
GI tract, thereby preventing digestion of the Cry protein (See
Impact of Protein Digestibility) and eliminating a formidable
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element of the GI tract barrier. Additionally aluminumhydroxide
is a known antigenic adjuvant (Mannhalter et al., 1985; Rimaniol
et al., 2004) and therefore could be responsible for the eﬀect
observed when the Cry proteins were delivered. Another detail
which calls into question the relevance of these results is that the
mice were often dosed with 100 μg Cry1Ac protein/25 g mouse
(∼4 mg/kg BW). While this may not seem like an exceedingly
large dose at ﬁrst glance, this amount of Cry1Ac translates into
at least 50,000-fold greater exposure than estimates of Cry1Ab
human intake (Hammond and Jez, 2011), which conservatively
presumed that Bt maize grain was consumed uncooked. These
experimental conditions clearly exceed any reasonable potential
human dietary intakes. Furthermore, since maize grain is nor-
mally processed (e.g., by cooking) before human consumption,
which denatures Cry proteins, the level of functionally active Cry
protein in food products derived from processed maize has been
estimated to be reduced by approximately two orders of magni-
tude (Section Impact of Heat on Stability). Thus the diﬀerences in
dietary exposure between the aforementioned mouse study and
humans would increase from 50,000 to 5,000,000 (Hammond and
Jez, 2011).
In addition to the lack of relevancy to potential health risks
from human consumption of Cry protein containing crops,
an attempt to reproduce these studies (Vázquez-Padrón et al.,
1999a,b, 2000a,b; Moreno-Fierros et al., 2000) in mice with
Cry1Ab failed to detect anti-Cry IgG antibodies. Adel-Patient
et al. (Adel-Patient et al., 2011) reported that IG administration
of puriﬁed Cry1Ab protein had no impact on immune response
in mice and conﬁrmed the earlier reports of the immunogenic-
ity of Cry1Ab administered by IP injection to mice, without any
evidence of allergenicity. One potential explanation for this dis-
crepancy in results is that Cry protein preparations used in the
studies where antibody production was observed were contam-
inated with E. coli endotoxin. The Cry proteins used in these
studies were produced and puriﬁed from E. coli but were not
apparently checked for endotoxin contamination. Additionally,
the routes of exposure and amounts of protein required to elicit
a response were very diﬀerent from the dietary exposure of Cry
proteins in GM crops (See Human Dietary Exposure Assessment
for Cry Proteins in Bt Crops). Given the low dietary exposures
to Cry proteins from consumption of foods derived from Bt
crops, the potential to induce or enhance an immune response in
humans is unlikely (Guimaraes et al., 2010; Hammond and Koch,
2012).
Cry Protein Binding to Mammalian Intestinal
Cells
In contrast to the information presented in Section “Receptor-
Mediated Selectivity of Bt Cry Proteins” on receptor-mediated
selectivity, Vázquez-Padrón et al. (2000b) reported binding of
Cry1Ac protein to BBMVs isolated from mouse small intestine.
Unlike the speciﬁc toxin/receptor binding that occurs in target
species, the binding appeared to be non-speciﬁc because of the
non-physiologically relevant concentrations of Cry1Ac protein
were used (1 μg Cry protein/1 μg BBMV). This concentration
is many orders of magnitude higher than the potential dietary
exposures a mammalian digestive tract might encounter from
consumption of food derived from Bt maize (Hammond and
Cockburn, 2008; See Human Dietary Exposure Assessment for
Cry Proteins in Bt Crops) and may have been directly respon-
sible for the observed binding simply due to the law of mass
action (i.e., high levels of Cry protein drove non-speciﬁc binding
of the protein to the mammalian BBMVs). The Cry1Ac concen-
tration used in these studies was too high to be toxicologically
relevant as it greatly exceeded levels toxic to target insect pests,
where binding to receptors occurs at much lower concentrations
(0.00001–0.001 μg Cry protein/μg BBMV). While one group
reported that an insecticidal Cry protein bound to rat BBMV,
they also note it did so with low aﬃnity. Additionally, the bound
protein could not be displaced by a 10,000-fold excess of unla-
beled Cry protein (Hofmann et al., 1988a). Taken together, the
low aﬃnity and inability to displace the labeled protein with unla-
beled protein indicates non-speciﬁc, or non-receptor-mediated,
binding. This directly contradicts the claims of Vázquez-Padrón
et al. (2000b) Similarly, other studies with BBMVs prepared from
bovine intestines (Shimada et al., 2006) indicate Cry1Ab protein
binds at low levels to the cytoskeletal protein actin, which is a
structural protein, but not to extracellular proteins that have been
identiﬁed as receptors for Cry protein binding on target insect
mid-GI-tract epithelia. The ability of Cry proteins to bind actin
is particularly relevant when considering the results of Vázquez-
Padrón et al. (2000b) because BBMVsmay form with intracellular
proteins outside the vesicle (Haase et al., 1978), and actin is
an intracellular protein. This technical limitation of the BBMV
model makes it possible that the binding detected by Vázquez-
Padrón et al. (2000b) was an artifact of the presence of actin
rather than evidence for speciﬁc Cry protein receptors in the gut
of mammals.
Hematotoxicity
In another study, Bt microbial spore preparations containing
various Cry proteins were reported to cause hematotoxicity in
mice when administered by oral gavage (Mezzomo et al., 2013).
It should be noted that this is in contrast to the absence of
ﬁndings on many other animal studies, which contained com-
prehensive hematology data, following repeated dietary expo-
sures to Bt microbials, individual Cry proteins, or Bt crops (see
Tables 3 and 4). This result could be due to spore components
other than Cry proteins as the cause of the hematologic eﬀects
because they used distilled water as the negative control and
not an appropriate control (Bt spores lacking the Cry genes).
Because the Bt spore formulation also contained many other bac-
terial proteins not present in the negative control (water), the
cause of this observed eﬀect is confounded with other compo-
nents and the results cannot be speciﬁcally attributed to Cry
proteins.
A few statistical re-analyses of data from 90-day toxicol-
ogy studies with Bt crops have been published in which the
authors alleged detection of new adverse eﬀects that were missed
in the original analysis (Séralini et al., 2007, 2009; Spiroux de
Vendômois et al., 2009). Among the claimed ﬁndings in these
statistical re-analyses were eﬀects on the hematopoietic system.
As noted by Bartholomaeus et al. (2013), the conclusions of these
re-analyses and other studies (Velimirov et al., 2008; Séralini
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et al., 2012), have been comprehensively rebutted by both aca-
demic scientists and regulatory authorities world-wide (FSANZ,
2011b; Arjó et al., 2013; Grunewald and Bury, 2013). Moreover,
the results of some of these studies (Velimirov et al., 2008) were
actually supportive of an absence of adverse eﬀects despite the
conclusions of the authors (FSANZ, 2011b).
Systemic Exposure in Susceptible
Populations
A recent paper reported the detection of Cry1Ab protein in the
serum of non-pregnant women, pregnant women, and the cord
blood of their fetuses (Aris and Leblanc, 2011). Detection was
performed with a commercially available ELISA immunoassay kit
that has been validated for use in detecting Cry1Ab protein in
grain/seed samples but not human serum. The authors did not
report that they had validated the assay for Cry1Ab protein lev-
els in human serum. The majority of reported serum “detects”
were at or below the limit of detection (LOD) for the commercial
kit used for grain detection. These points raise serious questions
about the accuracy of the data, especially in light of previous
reports that (1) a validated immunoassay to quantify Cry1Ab
protein in plasma (LOD 1 ng/ml) was unable to detect Cry1Ab
protein in any of the plasma samples collected from cows fed
MON 810 maize at 70% w/w (dry matter) in the diet for 1 or
2 months (Paul et al., 2008), and (2) Cry1Ab protein could not
be detected in the blood of pigs, which like humans are monogas-
tric animals, after consuming diets containing 38% Bt maize for
110 consecutive days (Walsh et al., 2012b). Given that diet data
were not reported for the test subjects, and that Cry1Ab is com-
monly used in both conventional and organic agriculture, linking
their ﬁndings to GM crop consumption is speculative. A simi-
lar response to Aris and Leblanc (2011) has been rendered by
risk assessment experts in Australia and New Zealand (FSANZ,
2011a).
Environmental Testing and
Assessment
Tiered testing with representative species to assess potential tox-
icity to NTOs was originally developed as a relevant and reli-
able process to make testing more eﬃcient, avoid unnecessary
tests for the assessment of conventional pesticides to NTOs,
and enable mutual acceptance of data by regulatory authorities
globally. Tiered testing is designed to ﬁrst represent worst-case
exposure scenarios in laboratory assays and only progress to
more realistic scenarios if the lower-Tiered tests fail to indi-
cate acceptable risk (Romeis et al., 2008). The Tiered hazard
assessment approach for Bt crops was ﬁrst developed by the
American Institute of Biological Sciences in 1996 and conﬁrmed
as an acceptable method of environmental hazard assessment by
a Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA)
Scientiﬁc Advisory Panel (SAP) on biopesticides in 1999. The
SAP agreed that the Tiered testing and assessment approach was
suitable for use with plant-incorporated protectants such as Bt,
and testing should include beneﬁcial invertebrates closely related
to target species and/or likely to be present in GM crop ﬁelds
and tomeet existing regulatory requirements as well as protection
goals (discussed further below). This has resulted in the develop-
ment of a harmonized Tier I NTO battery that has been used in
support of Bt crop registrations for approximately two decades
(Carstens et al., 2014).
Species tested in the Tier 1 battery are selected to protect val-
ued ecosystem services (e.g., pollination, decomposition, preda-
tion, and parasitism for biological control) or have a conservation
interest. Surrogate species that are selected for testing typically
meet three criteria, ecological relevance, reliability for labora-
tory testing with established and/or validated test guidelines, and
potential sensitivity based on taxonomic relatedness to the target
species, which has been a good predictor for biological activ-
ity for currently registered Cry proteins. Romeis et al. (2012)
provided guidance on how to best use information that inﬂu-
ences the scope of surrogate species testing for an insecticidal
trait. When the mode of action is well characterized, the spec-
trum of activity is narrow and exposure is limited and/or the
level and duration of exposure is well deﬁned, the scope of NTO
can potentially be reduced compared to the scenario when little
is known about the mode of action, activity is broad spectrum
and there are multiple routes of exposure at relatively high con-
centrations. Following this approach could limit the collection of
hazard data to those species that are relevant for the ecological
risk assessment.
Tier I high-dose studies can be broad in scope and allow con-
trol over experimental variables and exposure conditions that
produce statistically reliable results by testing a suﬃciently large
number of organisms at a limit dose (Romeis et al., 2011). A limit
dose is a single treatment level that is a suﬃciently high exposure
level (i.e., 10× a Tier I exposure estimate) that a large mar-
gin of safety is provided and a substance can be classiﬁed as
non-toxic at realistic ﬁeld exposure levels (Romeis et al., 2008).
Importantly, lack of adverse eﬀects in limit dose testing pro-
vides suﬃcient conﬁdence to address uncertainties, allowing risk
assessors to conclude that there is no unacceptable risk to the
environment and that no further data are required (Rose, 2007).
When screening studies conducted in a laboratory setting have
suggested potentially unacceptable risk, additional higher-Tier
studies can be designed to assess risk under more realistic expo-
sure conditions (Romeis et al., 2008). For example, Tiers II–IV
also provide deﬁnitive assessments by using laboratory studies
with reﬁned exposure estimates (Tier II), employing greenhouse
or semi-ﬁeld testing (Tier III), or utilizing ﬁeld testing (Tier
IV). These higher-Tier studies would only be sequentially imple-
mented if unacceptable adverse eﬀects were observed at the Tier
I screening level.
In addition to invertebrate testing, mammalian and avian
studies are performed. Mammalian studies used to support the
food and feed safety assessment are also used to support the
wild mammal assessment. Forty-two-day broiler growth studies
are performed to assess chronic risk and short-term quail feed-
ing studies are performed to support the avian assessment (EPA,
2010a).
After publication of Rosi-Marshall et al. (2007) which reported
impacts of Cry1Ab on Caddis ﬂies, EPA (2010a) started to require
chronic aquatic invertebrate testing to assess potential risk to of
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aquatic invertebrates from exposure to residues from Bt crops.
However, since the publication of Rosi-Marshall et al. (2007),
numerous researchers identiﬁed issues with the relevance and
reliability of the original caddis ﬂy study (Swan et al., 2009; Jensen
et al., 2010, summarized by Beachy et al., 2008; Parrott, 2008;
Wolt and Peterson, 2010). Criticisms of the study included: (1)
adverse eﬀects were not caused by toxicity of Cry1A but, rather,
by other diﬀerences between plant test substances (Jensen et al.,
2010); (2) the abundance of Trichoptera in streams containing
residues of Cry1A was not reduced (Chambers et al., 2007); and
(3) while postharvest crop residue was identiﬁed as the most
likely route of exposure (Carstens et al., 2012), aquatic exposure
to biotech crops has been shown to be limited temporally and
spatially with low to negligible exposure concentrations of Cry
proteins in post-harvest crop tissues (Swan et al., 2009; Chambers
et al., 2010; Jensen et al., 2010; Wolt and Peterson, 2010; Carstens
et al., 2012). Consequently, EPA (2010d, 2014) stopped uniformly
requiring additional aquatic invertebrate studies to assess hazard
to aquatic invertebrate species.
To evaluate the predictive and protective capability of the
Tier I NTO battery, Duan et al. (2010) performed a retrospec-
tive validation of the tiered approach for arthropod-active GM
events. This meta-analysis concluded that Tier I laboratory stud-
ies have been accurate and conservative in evaluating the envi-
ronmental safety of Bt crops. This same conclusion can also be
reached by comparing laboratory and ﬁeld results for Vip3Aa
in corn (Dively, 2005; Raybould and Vlachos, 2011), Cry1Ac
and Cry1F in soybean (EPA, 2014) and Cry1Ac and Cry2Ab2
in cotton (Whitehouse et al., 2005). These conclusions are also
consistent with ﬁndings by Rauschen et al. (2010), who rec-
ommended that potential eﬀects on key biocontrol agents (e.g.,
coccinellids) are most reliably assessed in lower-tiered lab stud-
ies because of the high level of natural variability observed in the
ﬁeld.
Over the past several years, a number of meta-analyses have
been published examining the safety of Bt crops to NTOs.
Marvier et al. (2007) performed an analysis across 42 ﬁeld exper-
iments and found that non-target invertebrates are more abun-
dant in Bt cotton and Bt maize ﬁelds than in non-transgenic
ﬁelds managed with chemical insecticides. Wolfenbarger et al.
(2008) performed an analysis using 45 ﬁeld studies across cotton,
maize, and potato and found no uniform eﬀects of Bt plant-
incorporated protectants on the functional guilds of non-target
arthropods. Duan et al. (2008) examined 25 studies that inde-
pendently assessed potential eﬀects of Cry proteins on honey
bee survival and found that the Cry proteins did not negatively
aﬀect the survival of either honey bee adults or larvae in labo-
ratory settings. Recently an update and review of the previous
NTOmeta-analyses was published by Naranjo (2009). This study
focused on two environmental elements: eﬀects on non-target
invertebrates and changes in insecticide use patterns since the
adoption of Bt maize and cotton. The review concluded that haz-
ards identiﬁed in the laboratory are commonly an artifact of the
experimental laboratory procedures and do not manifest in the
ﬁeld. For example, apparent negative eﬀects can be caused by Bt-
intoxicated prey or hosts because of their low quality, rather than
as a direct result of Bt toxicity. Additionally, the analyses clearly
demonstrated that potentially minor indirect negative eﬀects of
Bt crops demonstrated in the ﬁeld are insigniﬁcant in comparison
with alternative pest suppression measures based on use of tra-
ditional chemical insecticides. Taken together, this body of work
demonstrates the high level of taxonomic speciﬁcity for the Bt
proteins currently approved for cultivation.
In addition to the NTO assessment, the environmental assess-
ment includes a comparative assessment between the Bt crop
and the appropriate conventional control that is genetically sim-
ilar but lacks the introduced trait to address unintended eﬀects.
This assessment is conducted under diverse geographies to cap-
ture the range of environmental conditions. Speciﬁc phenotypic,
agronomic, and ecological characteristics are measured in the Bt
crop and the conventional control to evaluate whether the intro-
duction of the insect resistance has resulted in any changes that
might cause ecological harm in terms of altered weed character-
istics, susceptibility to pests, or adverse environmental impact.
Additionally, environmental interaction data are collected in ﬁeld
experiments for Bt crop and the conventional comparator to eval-
uate potential adverse eﬀects. These data include measurements
of disease and insect susceptibility and crop damage under natu-
ral infestation pressure. Further to the agronomic and phenotypic
evaluation, potential movement of transgenes from a GM crop
plants into wild relatives is assessed for a new pest resistance gene
in a new crop. This aspect of the assessment addresses uncertainty
regarding the potential eﬀect the Bt crop may have on plant pop-
ulations in the wild. This concern has been considered for each
of the Bt crops currently registered by the U.S. EPA (2010d). EPA
determined in these assessments that there is no signiﬁcant risk of
gene capture and expression of any Bt endotoxin by wild or weedy
relatives of soybean and corn in the U.S. territories. However, for
cotton there is a possibility for gene transfer in locations where
wild or feral cotton relatives exist. Therefore, EPA requires strin-
gent sales and distribution restrictions on Bt cotton within these
geographic areas to prevent outcrossing or hybridization from the
crop to sexually compatible relatives.
Assessing Potential Interactions
between Introduced Proteins in
Combined-Trait Crops to Support the
Safety Assessment
To improve the eﬃcacy, pest spectrum, and durability of crops
producing plant incorporated protectants (PIPs), either products
producing individual PIPs have been combined through conven-
tional breeding or individual events have been produced that
express more than one PIP. These products have been developed
with PIPs that have been shown to act independently and do not
exhibit cross-resistance (EPA, 2008, 2010b). The focus of this sec-
tion on safety assessment for combined trait PIPs and the impact
of combination of PIPs on target pests is outside the scope of this
review and has recently been covered in a comprehensive review
(Head and Greenplate, 2012).
As the number of transgenic traits has increased, the number
of genes potentially introduced into a single GM crop product has
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also increased and has led to questions whether such traits might
interact. According to EFSA (2009d), “In the case of GM plants
obtained through conventional breeding of parental GM lines
(stacked events), possible interactions between the expressed pro-
teins, new metabolites, and original plant constituents should be
assessed. If the potential for adverse interactions is identiﬁed,
feeding trials with the GM food/feed are required.” The subject
of protein interactions in GM crops has recently been examined
in detail by Steiner et al. (2013), who present a decision-making
process for evaluating whether the potential for adverse eﬀects is
present in combined-trait products. For over a decade, combina-
tions of diﬀerent Cry proteins have been introduced into food and
feed crops to expand the number of insect pests that can be con-
trolled and to reduce the potential for the development of insect
resistance to the Cry insect-control proteins (Bates et al., 2005).
Thus, the means by which combined-trait products are evaluated
are particularly relevant to the deployment of Bt-containing GM
products.
Many regulatory authorities have developed speciﬁc data
requirements for import and/or cultivation approval that enable
bridging to, and transportability of, existing product safety pack-
ages for the single trait arthropod-active products. As an example,
the U.S. EPA (2009a,b) codiﬁed their requirements to bridge
existing data from a previously registered crop with an insect-
control trait to a new combined-trait insect-control product. It
is implicit with the approach, provided no interaction (synergy)
is observed with the largest combination of insecticidal prod-
ucts (e.g., A × B × C), that no interaction will be evident in
smaller sub-combinations of the largest combined-trait product
(e.g., A× B, B×C, A×C). The ﬁrst requirement of the approach
is conﬁrmation that the presence and structure of the inserted
material has been conserved in the combined-trait product. The
second requirement is that expression of the arthropod-active
trait is comparable in the single and combined-trait product,
which conﬁrms no biologically meaningful increase in expo-
sure to NTOs. The third requirement is demonstrating a lack of
synergism between arthropod-active traits using sensitive insect
bioassays. Demonstrating the lack of synergism permits the appli-
cation of the principle of independent assessment, which has a
long history of use in toxicology. This principle states that if each
substance in a mixture acts independently, and the substances are
below their NOAELs, their toxicity can be assessed independently
(EPA, 2009a,b). As applied to Bt crops, satisfying the require-
ments of this principle enables the use of existing safety studies
performed separately for the individual products to assess the
safety of the combined-trait product. EPA (2009a) has taken the
position that for insecticidal traits with a record of proven safety,
unless a greater than 10-fold degree of synergism is observed,
there is no need to test for human health or non-target eﬀects.
However, in cases where Bt proteins with diﬀerent, and especially
novel, modes of action are being combined, the EPA (2009b) has
stated that they would be justiﬁed in requiring additional testing
for human health and NTOs eﬀects for levels of synergism as low
as ﬁvefold.
Cry proteins that have been shown to be additive or demon-
strate potentiation of toxicity in the target insect have not been
associated with similar eﬀects in non-target mammalian and
avian species (Hammond et al., 2013). For example, Cry35Ab1
potentiates the activity of Cry34Ab1 against corn rootworm pests,
but no evidence of toxicity was observed when the combina-
tion was tested in poultry or mice (McNaughton et al., 2007;
Juberg et al., 2009), which would not be expected considering
the margin of safety of each one individually. There has been
no evidence of toxicity in animal feeding studies of individual
Cry proteins or mixtures of Cry proteins in Bt microbial pes-
ticide formulations (McClintock et al., 1995; WHO/IPCS, 1999;
Betz et al., 2000; Siegel, 2001; Brake et al., 2003; Flachowsky
et al., 2005; Taylor et al., 2005; McNaughton et al., 2007; OECD,
2007; Taylor et al., 2007; Federici and Siegel, 2008; Scheideler
et al., 2008). As noted by Hammond et al. (2013), “These
results are similar to what is observed in the safety assess-
ment of mixtures of small molecules that have been individually
assessed for safety: toxic (or pharmacological, metabolic, and
pharmacokinetic) eﬀects are not observed when the individ-
ual components of the mixture are administered at doses well
below their toxicity thresholds (Seed et al., 1995; Groten et al.,
1997).”
Likewise, there has been no evidence of any treatment-related
adverse eﬀects in 90-day rat toxicology studies carried out with
Bt crops regardless of whether the crops contained one or more
Cry proteins (Table 4). There was no evidence of synergistic tox-
icity in crops with combined (stacked traits), similar to what was
observed years ago when Bt microbial formulations were tested
in acute, subchronic, and chronic toxicity studies. These studies
(Table 4) were undertaken early in the development of Bt micro-
bial formulations when their acute mode of action was not clearly
deﬁned.
In a recent EFSA opinion on 59122 × 1507 × NK603, a
combined-trait maize product expressing three Cry proteins and
three herbicide-tolerance proteins, the panel stated, “As the com-
position of maize 59122 × 1507 × NK603 is comparable with
that of non-GM maize varieties and the single events and also
no indication for interaction between the newly expressed pro-
teins was found, the GMO Panel is of the opinion that no
additional animal safety studies are required” (EFSA, 2009c).
As indicated by this and the other examples in Table 5, the
weight of evidence for existing combined-trait products points
to no apparent interactions among the traits. Even as new
kinds of proteins (e.g., transcription factors) are introduced into
crops, existing methods such as agronomic evaluation, com-
positional analysis, and hypothesis-based food and feed assess-
ments can be used to test for protein–protein interactions in
combined-trait products (Parrott et al., 2010; Steiner et al.,
2013).
Benefits of Bt Crops
Adoption of Bt crops has been very rapid and attests to their pop-
ularity with farmers, who are the primary beneﬁciaries of their
value. For the ﬁrst time in 2012 and continuing in 2013, develop-
ing countries planted more hectares of GM crops than industrial-
ized countries (James, 2013). Herbicide tolerance was the most
widely used trait, but insect-resistant GM crops containing Bt
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proteins were planted on 76 million hectares in 2013, with most
of that being maize and cotton. Almost 60% of Bt acreage was
planted with stacked traits that include Bt with herbicide toler-
ance. It is noteworthy that Bt maize (MON810) is grown in ﬁve
EU countries (Spain, Portugal, Romania, the Czech Republic, and
Slovakia) and in 2013 four insect-resistant Bt brinjal (eggplant)
varieties were approved for seed production and initial commer-
cialization in Bangladesh. The start of limited cultivation of Bt
brinjal is expected in 2014. Brinjal suﬀers considerable insect
damage and as a result the adoption of Bt brinjal in Bangladesh
is expected to improve the incomes of thousands of small-holder
farmers and consumers in that country, as well as to reduce expo-
sures to chemical insecticides and pesticide poisonings in the
areas that adopt the technology.
The most widely used Bt vegetable crop is sweet corn. Shelton
et al. (2013) compared sweet corn varieties grown in New York,
Minnesota, Maryland, Ohio, and Georgia where the primary
insect pest was Helicoverpa zea. They demonstrated that non-
sprayed Bt varieties produced more clean, marketable ears than
conventional isolines, even when the conventional corn was
sprayed with chemical insecticides up to eight times. In the most
comprehensive report that summarizes global data on GM crops
from 1996 to 2012 (Brookes and Barfoot, 2014), the authors
reported increased farm income, decreased pesticide use, and
decreased greenhouse gasses (GHG), which have been attributed
to use of GM crops. The greatest gain, as a result of reduced
pesticide use, was for insect-resistant crops. There were 48 and
26% reductions in insecticidal active ingredients used on insect-
resistant maize and cotton, respectively. These reductions in
insecticide usage rates were for both developed and developing
countries, but this beneﬁt was most pronounced for Bt cotton
grown in developing countries. Reduced GHG were primarily
the result of the adoption of no-till practices. Although no-
till is not necessarily associated with Bt crops, use of Bt crops
is expected to lead to reduced fuel consumption due to fewer
passes in the ﬁeld for application of pesticides. As a result of
decreased input costs and increases in crop yields, farm income
was improved. Income in 2012 was increased by $6.7 billion
and $5.5 billion for insect-resistant maize and cotton, respec-
tively. For cotton, more than 75% of the increased income was
in developing countries.
Adoption of Bt cotton has greatly reduced the abundance of
targeted pests in cotton and in other crops with proximity to
cotton that are impacted aﬀected by polyphagous target pests
(Naranjo, 2011). Additionally, reductions in insecticide use have
facilitated and enabled integrated pest management (IPM) that,
when appropriately managed can play an important part in sup-
pression of other key and periodic pests in cotton. Furthermore,
use of Bt cotton has helped to avoid or limit the use of broad-
spectrum pesticides against the bollworm complex, which has
reduced impacts to beneﬁcial insects that are natural enemies
to other cotton pests (Naranjo, 2011). Consequently, introduc-
tion of Bt cotton has enabled the success of biologically based
IPM programs and for insecticide use to be nearly eliminated
in a system previously dominated by chemical insect control
measures.
Reduced Chemical Insecticide Use and
Applicator Exposure
A major advantage of Bt insect control has been a dramatic
reduction in the need for application of conventional small-
molecule, chemical insecticides over Bt commodity crops, most
particularly corn and cotton. Adoption of Bt crops has resulted
in a net reduction estimated at 50 million kilograms of pre-
dominantly organophosphate insecticides from 1996 to 2011
(Brookes and Barfoot, 2013); this is a considerable advantage
in areas where small-holder agriculture is the norm and appli-
cation is often by hand, as indicated by reductions in pesti-
cide poisoning events (Hossain et al., 2004; Parrott et al., 2010;
Kouser and Qaim, 2011). In Burkina Faso in West Africa,
the planting of Bt cotton has enabled farmers to reduce the
number of chemical insecticide sprays during a growing sea-
son from 6 to 2 applications (James, 2010). India reported
pesticide use on Bt cotton has been cut at least in half. In
a survey conducted for the years 2002–2008, Indian farm-
ers reported Bt cotton use prevented at least 2.4 million
TABLE 5 | GM maize and cotton containing multiple Cry proteins positively evaluated by EFSA.
Event(s) Traitsa Reference
Maize
MON810 × MON863 Cry1Ab, Cry3Bb1, NptII EFSA (2005a)
MON810 × MON863 × NK603 Cry1Ab, Cry3Bb1, CP4 EPSPS, NptII EFSA (2005b)
DAS-59122–7 Cry34Ab1/Cry35Ab1, PAT EFSA (2007)
MON89034 Cry2Ab2, Cry1A.105 EFSA (2008)
MON89034 × MON88017 Cry1A.105, Cry2Ab2, Cry3Bb1, CP4 EPSPS EFSA (2010c)
DAS-01507-1 × DAS-59122-7 Cry1F, PAT, Cry34Ab1/Cry35Ab1 EFSA (2009a)
MON810 × MON88017 CP4 EPSPS, Cry1Ab, Cry3Bb1 EFSA (2009b)
MON89034 × TC1507 × MON88017 × DAS-59122-7 Cry1A.105, Cry2Ab2, Cry1F, PAT, Cry3Bb1, CP4 EPSPS, Cry34Ab1/Cry35Ab1 EFSA (2010a)
Bt11 × MIR604 × GA21 Cry1Ab, PAT, mCry3A, PMI, mEPSPS EFSA (2010d)
Cotton
DAS-24236-5 × DAS-21Ø23-5 Cry1Ac, Cry1F, PAT EFSA (2010b)
aEPSPS, 5-enolpyruvylshikimate-3-phosphate synthase; NptII, neomycin phosphotransferase II; PAT, phosphinothricin-N-acetyltransferase; PMI, phospho-mannose
isomerase.
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cases of pesticide poisoning, saving $14 million (US dollar equiv-
alent) in annual health costs (Kouser and Qaim, 2011). Further,
there will be continued reductions in the large quantities of
soil insecticides that were historically used for control of corn
rootworms with the continued adoption and improved eﬃ-
cacy as coleopteran-resistant Bt maize adoption grows in the
future.
Reduced Mycotoxin Contamination of Grain
Another beneﬁt of Bt insect control is the potential for reduced
levels of mycotoxin contamination. In general, insect-damaged
grain and other plant tissues are more susceptible to infection
by fungi than intact tissues. Some of the fungi present in maize-
growing areas and able to colonize maize include mycotoxin-
producing fungi such as Fusaria (Hammond et al., 2004).
Fusarium species produce the mycotoxin fumonisin, which is
known to cause illness in farm animals and possibly in humans
(Li et al., 2001; CAST, 2003; Marasas et al., 2004; Wu et al., 2004;
Sun et al., 2007). Several studies conducted in diverse world areas,
and under a wide range of environmental conditions (Hammond
et al., 2004; Folcher et al., 2010; Ostry et al., 2010), have found
that grain from Bt maize contains lower fumonisin levels than
that from non-Bt maize. Reduced fumonisin contamination in Bt
maize cannot be guaranteed, but a reduction in fumonisin con-
tamination has generally been observed. This beneﬁt is presumed
to be a result of the decrease in insect damage, leading to fewer
ports of entry for fungal infection (Hammond et al., 2004).
Summary
Cry Bt proteins, whether in microbial pesticide products or
expressed in Bt crops, have been used and consumed safely for
decades. The levels of Cry Bt protein in GM crops are very
low and are often reduced further by food processing. In addi-
tion, extensive testing of Bt proteins, single-Bt trait crops, and
stacked trait crops containing Bt proteins has not revealed any
harm to non-target insects and other non-target species, includ-
ing humans. This environmental safety proﬁle for Bt crops largely
reﬂects the high level of taxonomic speciﬁcity that has been
achieved with Bt crops currently approved for cultivation. Use
of Bt crops provides beneﬁts beyond insect control, such as sig-
niﬁcantly reducing small-molecule insecticide use for target pests
controlled by Bt proteins, reducing applicator exposure to small-
molecule insecticides, reducing greenhouse gasses emissions by
minimizing ﬁeld spraying with self-propelled sprayers or other
motorized equipment, and by potentially reducing fumonisin
levels in maize grain.
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